STAT - Reporting from the frontiers of health and medicine

Biotech

Health

By Gabrielle Glaser

Politics

Pharmalot Vertex angers U.K. cystic fibrosis patients with a delay in submitting data for its newest therapy
Health Experts decry FDA’s halting of a high-profile Covid-19 study over approvals
In the Lab Scientists 3D-map the ‘little brain of the (rat) heart’
Health Watch: How researchers will study Covid-19 vaccines
Health New research rewrites history of when Covid-19 took off in the U.S. — and points to missed chances to stop it

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Startup Spotlight: Going after immune regulators when they cause disease instead of prevent it
A pharma effort to work with European officials to develop needed drugs is a ‘failure’
Pharmalittle: Moderna executives cashed out big time; should we have ‘quality scores’ for manufacturing drugs?

Exclusive

Special Report

Special Report

Health

Health

By Gabrielle Glaser

Politics

Health He experienced a severe reaction to Moderna’s Covid-19 vaccine candidate. He’s still a believer
Biotech Moderna executives have cashed out $89M in shares this year, as stock price has soared on vaccine hopes
Health New research rewrites history of when Covid-19 took off in the U.S. — and points to missed chances to stop it
Health Experts decry FDA’s halting of a high-profile Covid-19 study over approvals
Health The Covid-19 Tracker
Health The world needs Covid-19 vaccines. It may also be overestimating their power
Health ‘Forced to retract completely into ourselves,’ a mother and son confront cancer in the age of Covid-19
Health Hospital records hold valuable Covid-19 data. Making it usable is time-consuming work